Correlation Between Synmosa Biopharma and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Synmosa Biopharma and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synmosa Biopharma and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synmosa Biopharma and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Synmosa Biopharma and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synmosa Biopharma with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synmosa Biopharma and Sinphar Pharmaceutical.
Diversification Opportunities for Synmosa Biopharma and Sinphar Pharmaceutical
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Synmosa and Sinphar is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Synmosa Biopharma and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Synmosa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synmosa Biopharma are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Synmosa Biopharma i.e., Synmosa Biopharma and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between Synmosa Biopharma and Sinphar Pharmaceutical
Assuming the 90 days trading horizon Synmosa Biopharma is expected to under-perform the Sinphar Pharmaceutical. In addition to that, Synmosa Biopharma is 1.36 times more volatile than Sinphar Pharmaceutical Co. It trades about -0.16 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about 0.09 per unit of volatility. If you would invest 3,080 in Sinphar Pharmaceutical Co on November 30, 2024 and sell it today you would earn a total of 65.00 from holding Sinphar Pharmaceutical Co or generate 2.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Synmosa Biopharma vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| Synmosa Biopharma |
| Sinphar Pharmaceutical |
Synmosa Biopharma and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Synmosa Biopharma and Sinphar Pharmaceutical
The main advantage of trading using opposite Synmosa Biopharma and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synmosa Biopharma position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.| Synmosa Biopharma vs. U Media Communications | Synmosa Biopharma vs. Univacco Technology | Synmosa Biopharma vs. Kinsus Interconnect Technology | Synmosa Biopharma vs. China Mobile |
| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |